Treace Medical Concepts
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Treace Medical Concepts's past years’ income statements indicate that its last revenue has increased compared to the previous period by 32% to $187,118,000. Profit margin reached -26%. Total operating expenses were $203,365,000.

Profit Margin

Treace Medical Concepts, Inc. (NASDAQ:TMCI): Profit margin
2019 39.41M -5.10M -12.95%
2020 57.36M -6.44M -11.24%
2021 94.41M -24.61M -26.07%
2022 141.83M -47.29M -33.35%
2023 187.11M -49.52M -26.47%

TMCI Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
187.11M141.83M94.41M57.36M39.41M
Cost of revenue
35.18M27.52M17.82M12.47M7.63M
Gross profit
151.93M114.31M76.59M44.89M31.78M
Operating exp.
Research and development
15.44M13.58M10.20M5.84M5.07M
Selling and marketing
140.89M102.57M64.46M31.65M25.78M
Total operating expenses
203.36M149.15M93.10M44.04M35.32M
Operating income
-51.42M-34.84M-16.51M-891K-3.53M
Other income (expenses), net
1.90M-7.97M-4.04M-4.52M-730K
Income before tax
-49.52M-42.81M-20.55M-3.66M-4.26M
Income tax expense
04.48M4.06M2.77M841K
Net income
-49.52M-47.29M-24.61M-6.44M-5.10M
Earnings per share
Basic EPS
-0.81-0.86-0.45-0.13-0.09
Diluted EPS
-0.81-0.86-0.45-0.13-0.09
Data sourceData sourceData source